ArticleScientific reports2026
Effect of asymmetry on frustrated crystallization.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Partial bonding in colloidal systems is often regarded as an obstacle to order, as it introduces geometric frustration. Yet, frustration can instead serve as a powerful design principle for controlling the formation of porous crystalline monolayers. By systematically varying the asymmetry in patch placement on anisotropic rhombic platelets, we investigate how partial bonding and geometric frustration can be tuned to direct polymorph selection, modulate porosity, and optimize crystal yield. This reveals an alternative route to crystallinity in patchy colloids - one that relies not on maximizing bonding, but on purposefully limiting it. Our findings establish a new strategy for programming functionality in colloidal materials, with relevance for the rational design of supramolecular architectures, DNA-based nanomaterials, and stimuli-responsive assemblies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.